Skip to content

IDEAYA Biosciences, Inc. IDYA Short-Term Investments

Short-Term Investments at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$912M+0.6%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$222.01M+40.3%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$621M-22.9%
Erasca, Inc. logo
Erasca, Inc.ERAS
$196.53M-16.0%
Nuvation Bio logo
Nuvation BioNUVB
$408.34M-1.3%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$492.22M+229%

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.36B+104%
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s short-term investments?
IDEAYA Biosciences, Inc. (IDYA) reported short-term investments of $513.68M in Q1 2026.
How has IDEAYA Biosciences, Inc.'s short-term investments changed year-over-year?
IDEAYA Biosciences, Inc.'s short-term investments decreased by 8.7% year-over-year, from $562.51M to $513.68M.
What is the long-term trend for IDEAYA Biosciences, Inc.'s short-term investments?
Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s short-term investments has grown at a 20.0% compound annual growth rate (CAGR), from $211.55M to $526.56M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.